---
$id: https://graph.org.ai/products/commodity/51282316
$type: Product
source: UNSPSC
code: "51282316"
title: "Erythromycin estolate"
class: "51282300"
classTitle: "Erythromycins"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Erythromycin estolate

**UNSPSC Code**: 51282316
**Class**: [Erythromycins](Erythromycins.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a macrolide antibiotic with the molecular formula C40H71NO14.C12H26O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XRJ2P631HP, chemically known as erythromycin, n-demethyl-n-(methyl-11c)- but more generally known as erythromycin estolate, which bears US NIH Compound Identifier 12560. European Medicines Agency schedules Erythromycin estolate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01941MIG. Most nations, for tariff and trade purposes, schedule erythromycin estolate under HS 29415000 and SITC 54139. As of Q4 2014, ERYTHROMYCIN ESTOLATE remains US FDA's Preferred Term for this commodity. Erythromycin estolate bears US NLM identifiers UMLS ID C0014809 and NCI Concept Code C47986. SMILES: CCCCCCCCCCCCOS(=O)(=O)O.CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)OC(=O)CC)(C)O)C)C)O)(C)O.

